VISEN Pharmaceuticals has issued a supplemental notice ahead of its annual general meeting (AGM), confirming that the session will proceed as scheduled on 26 June 2026 at 10:00 a.m. at Room 1701, 1788 Square, No. 1788 West Nanjing Road, Jing’an District, Shanghai.

Key additions to the AGM agenda: 1. Ordinary Resolutions 2(e)–2(g) propose the appointments of Mr. Roy Paul Khoury, Ms. Sherrie Lynn Glass and Mr. Michael J. Chang as non-executive directors. 2. A revised proxy form—separate from the original proxy form dated 27 April 2026—must be completed for voting on the new resolutions. Submission to the company’s Hong Kong branch share registrar, Computershare Hong Kong Investor Services Limited, is required at least 48 hours before the meeting.

The supplemental notice states that all other information in the original AGM notice remains unchanged. Voting on all resolutions will be conducted by poll.

As at the notice date of 17 June 2026, the board comprises one executive director, two non-executive directors and four independent non-executive directors.